期刊文献+

血管性痴呆患者应用参龙汤改善神经功能缺损的临床研究 被引量:16

Clinical study on shenlong tang for improving neurological impairment in patients with vascular dementia
暂未订购
导出
摘要 目的:观察参龙汤改善血管性痴呆(vasculardementia,VD)患者神经功能缺损的临床疗效。方法:参照WHO公布的美国精神病学会VD诊断标准(DSM-IV),入选18例(36例次)VD患者,随机、安慰剂对照,双盲给药,自身前后交叉试验为研究方法,选择简易智能量表(MMSE)、Blessed行为量表(BBS)于疗程前后统计分值变化进行疗效评估。结果:参龙汤治疗VD患者18例,显效3例,有效9例,无效6例,临床总体有效率为67%,对VD患者的认知障碍和行为均有明显改善作用,其效应明显优于安慰剂(P<0.05)。该药有提高VD患者的智力量表成绩,改善其日常生活自理能力、临床症状和神经功能缺损的作用;对VD患者血脂、血液黏度及脑葡萄糖代谢亦有一定改善作用。结论:肾虚精亏,气虚血瘀是VD的主要病机,补肾填精,益气活血法治疗本病的重要方法,参龙汤对VD确有一定疗效,安全可靠。 AIM:To observe the clinical effect of shenlong tang in improving neurological im pairment in patients with vascular dementia(VD). METHODS:Eighteen patients with VD were selected according to the diagnostic c riteria of the Diagnostic and Statistical Manual of Mental Disorder-Fourth Edi tion(DSM-IV) published ty the American Psychiatric Association.It was a random ized,placebo-controlled,double-blind and auto-crossed study.The curatice e ffect was evaluated based on the statistics with mini mental state examination(M MSE)and Blessed behavior schedule(BBS)before and after treatment. RESULTS:Among the 18 patients in the shenlong tang group,notable effect was a chieved in 3 cases,fair in 9 cases and unchanged in 6 cases.The total effective rate of shenlong tang group was 67% ,significantly higher than that of the plac ebo group (P< 0.05).The results of MMSE and BBS showed that shenlong tang played a curative role not only in improving patients'disturbance of intelligence and behavior, but also in improving daily self-care abitlity,clinical symptoms an d neurological impairment.It also played a certain role in improving lipoprotein ,blood viscosity and cerebral glucose metabolism. CONCLUSION:The main pathogenic mechanism of VD is the deficiency of the kidne y essence,deficiecy of qi and blood stasis.So the principal treatment of VD is t o reinforce the didey,supplement qi and activate blood circulation.Shenling tang has a certain safe and reliable role in treatment of VD.
出处 《中国临床康复》 CSCD 2004年第4期679-681,共3页 Chinese Journal of Clinical Rehabilitation
基金 国家中医药管理局中医药科技研究基金课题资助(2000-01LP07)~~
  • 相关文献

参考文献4

二级参考文献44

  • 1刘燕池,蒋云娜,张沁园.益智防呆汤防治口服三氯化铝所致痴呆小鼠作用机制的实验研究[J].中国中医基础医学杂志,2000,6(4):15-20. 被引量:4
  • 2贾健民,贾健平,张昱、刘多三、饶明俐.大鼠脑反复缺血致不可逆性学习记忆障碍的研究[J].心理学报,1995,27(1):60-77. 被引量:55
  • 3廖方正,李青.脑力康对老年痴呆病的疗效观察──附:31例病例报告[J].成都中医药大学学报,1996,19(1):20-23. 被引量:23
  • 4LINDSAY J,HEBERT R,ROCKWOOD K.The Canadian study of heath and aging: risk of vascular dementia[J].Stroke,1997,28(3):526-530.
  • 5MORONEY JT,TANG MX,BERGLUND L,et al.Low-density lipoprotein cholesterol and the risk of dementia with strok[J].Eur J Nuel Med,1999,26(3):239-245.
  • 6CURB JD,RODRIGUEZ BL,ABBOTT RD,et al.Longituclinal association of vascular and Alzhemier,dementia,diabetes,and glucose tolerance[J].Neurology,1999,52(5):971-975.
  • 7FORETTE F,SEUX ML,STAESSEN JA,et al.Prevetion of dementia in randomized double-blind placebo-controlled systolic hypentention in Europe(Sgst-Eur)trail[J].Lancet,1998,352(9137):1347-1351.
  • 8SKOOG I,LERNFELT B,LANDAHL S,et al.15 year longitudinal study of blood pressure and dementia[J].Lancet,1996,374(9017):1141-1146.
  • 9FRISONI M,ANGELO D,BIANCHETTI N,et al.Association of Apolipoproprotein with vascular dementia[J].JMAM,1994,271(17):1317.
  • 10ROSES AD,SAUNCLER AM.Apolipoprotein E E4 allele and risk of denmentia[J].AMJM,1995,1273(5): 374-375.

共引文献212

同被引文献210

引证文献16

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部